The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by an incompletely reversible limitation in airflow. A physiological variable--the forced expiratory volume in one second (FEV1)--is often used to grade the severity of COPD. However, patients with COPD have systemic manifestations that are not reflected by the FEV1. We hypothesized that a multidimensional grading system that assessed the respiratory and systemic expressions of COPD would better categorize and predict outcome in these patients. METHODS: We first evaluated 207 patients and found that four factors predicted the risk of death in this cohort: the body-mass index (B), the degree of airflow obstruction (O) and dyspnea (D), and exercise capacity (E), measured by the six-minute-walk test. We used these variables to construct the BODE index, a multidimensional 10-point scale in which higher scores indicate a higher risk of death. We then prospectively validated the index in a cohort of 625 patients, with death from any cause and from respiratory causes as the outcome variables. RESULTS: There were 25 deaths among the first 207 patients and 162 deaths (26 percent) in the validation cohort. Sixty-one percent of the deaths in the validation cohort were due to respiratory insufficiency, 14 percent to myocardial infarction, 12 percent to lung cancer, and 13 percent to other causes. Patients with higher BODE scores were at higher risk for death; the hazard ratio for death from any cause per one-point increase in the BODE score was 1.34 (95 percent confidence interval, 1.26 to 1.42; P<0.001), and the hazard ratio for death from respiratory causes was 1.62 (95 percent confidence interval, 1.48 to 1.77; P<0.001). The C statistic for the ability of the BODE index to predict the risk of death was larger than that for the FEV1 (0.74 vs. 0.65). CONCLUSIONS: The BODE index, a simple multidimensional grading system, is better than the FEV1 at predicting the risk of death from any cause and from respiratory causes among patients with COPD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The BODE index [BMI, airflow limitation (forced expiratory volume in one second), dyspnea and 6-min walk distance], which has been externally validated in at least 13 additional cohorts following the original derivation. The BODE index has been cited as the prognostic model of choice by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), and it formed the basis for listing recommendations in the 2014 ISHLT candidate selection guidelines. (4, 166–168)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [166]
In the citing paper
“Although COPD remains the most common indication for lung transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
In the citing paper
“the BODE score (body mass index, degree of airway obstruction, dyspnea, and exercise capacity score) is still the most important indicator, and along with it, FEV1 and the presence or absence of acute exacerbation determine whether transplantation is possible based on the presence or absence of evidence for pulmonary arterial hypertension (PAH), as summarized in Table 2 [3,42].”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Lung Function Testing: Selection of Reference Values and Interpretative Strategies
(1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1202 · Cited by 2,510
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Evaluation of Clinical Methods for Rating Dyspnea
Mahler, D. A., & Wells, C. K. (1988) · Chest · doi:10.1378/chest.93.3.580 · Cited by 1,822
Research works printed but not linked: 1
- Burrows B, 1991, Eur Respir Rev, 1, 340
Cited by
Items 301–400 of 1,007
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
Glaab, T., Vogelmeier, C., & Buhl, R. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-79 · Cited by 130
“Relevance So far the only multidimensional scoring system that has gained broader acceptance is the BODE index which has been developed as a prognostic marker for COPD patients in an attempt to integrate not only the respiratory but also the systemic expressions of COPD in a single grading system [70].”
BackgroundSarcopenia in COPD: relationship with COPD severity and prognosis
Costa, T. M. D. R. L., Costa, F. M., Moreira, C. A., Rabelo, L. M., Boguszewski, C. L., & Borba, V. Z. C. (2015) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132015000000040 · Cited by 141
“(9) We evaluated COPD prognosis using the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index, stratifying the patients into four quartiles, the fourth being the most severe.(14)”
MethodMetabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease
Poulain, M., Doucet, M., Drapeau, V., Fournier, G., Tremblay, A., Poirier, P., & Maltais, F. (2008) · Chronic Respiratory Disease · doi:10.1177/1479972307087205 · Cited by 145
The midbrain periaqueductal gray as an integrative and interoceptive neural structure for breathing
Harrison, O. K., Subramanian, H. H., Ezra, M., & Pattinson, K. T. S. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.020 · Cited by 133
Li, S., Li, J., Wang, M., Xie, Y., Yu, X., Sun, Z., Ma, L.-J., Zhang, W., Zhang, H., Cao, F., et al. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-197 · Cited by 134
“The cut-off point for the 6MWD was approximately 350 m [29] and the minimal important difference in COPD patients is 25 m [30].”
BackgroundLung transplantation: indications and contraindications
Weill, D. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.06.141 · Cited by 137
“(55) assigned a score from 0 to 10, with a higher score indicating more severe disease and a worse survival (a BODE score of 7–10 was associated with a mortality of 80% at 4 years, whereas a score of 5–6 conferred a mortality of 60% at 4 years) and proved to be a better indicator of survival than the spirometric stagi…”
BackgroundNatural history and mechanisms of COPD
Lange, P., Ahmed, E., Lahmar, Z. M., Martínez, F. J., & BOURDIN, A. A. (2021) · Respirology · doi:10.1111/resp.14007 · Cited by 144
de-Torres, J. P., Casanova, C., Hernández, C., Abreu, J. A., de Garcini, A. M., Aguirre‐Jaime, A., & Celli, B. R. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-72 · Cited by 129
“Postbronchodilator FEV1, FVC, FEV1/FVC and IC/TLC were determined taking the European Community for Steel and Coal for Spain reference [16] using a Jaegger 920 MasterLab® Body Box.”
Self-citationLongitudinal deteriorations in patient reported outcomes in patients with COPD
Oga, T., Nishimura, K., Tsukino, M., Sato, S., Hajiro, T., & Mishima, M. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2006.04.001 · Cited by 125
“Dyspnoea is an important outcome in COPD, because it is the most frequent symptom that COPD patients complain about, and it is strongly related to mortality.(29,30) However, its longitudinal change has rarely been analyzed.”
BackgroundWacker, M. E., Jörres, R. A., Karch, A., Wilke, S., Heinrich, J., Karrasch, S., Koch, A., Schulz, H., Watz, H., Leidl, R., et al. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0238-9 · Cited by 128
“The BODE index [12] as established multidimensional grading system in COPD was calculated in addition based on body mass index (BMI, defined as weight in kilograms/height in squared meters), FEV1 % pred.”
MethodRivera, M. P., Tanner, N. T., Silvestri, G. A., Detterbeck, F. C., Tammemägi, M. C., Young, R. P., Slatore, C. G., Caverly, T. J., Boyd, C. M., Braithwaite, D., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201805-0986st · Cited by 130
Gupta, D., Agarwal, R., Aggarwal, A. N., Maturu, V. N., Dhooria, S., Prasad, K. T., Sehgal, I. S., Yenge, L. B., Jindal, A., Singh, N., et al. (2013) · Lung India · doi:10.4103/0970-2113.116248 · Cited by 140
“) are useful in predicting mortality, exacerbations, and risk of hospitalizations.[166,167] Their predictive ability has been inconsistent when applied to different populations.”
Martinez, C. H., Chen, Y., Westgate, P., Liu, L. X., Murray, S., Curtis, J. L., Make, B. J., Kazerooni, E. A., Lynch, D. A., Marchetti, N. T., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201185 · Cited by 128
“The BODE index was calculated using 6MWD, FEV1 % predicted, MMRC and body mass index (BMI), as previously described.(7)”
MethodRecommendations for epidemiological studies on COPD
Bakke, P. S., Rönmark, E., Eagan, T., Pistelli, F., Annesi‐Maesano, I., Maly, M., Meren, M., Vermeire, P. A., Vestbo, J., Viegi, G., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00193809 · Cited by 143
Genetic Association Analysis of Functional Impairment in Chronic Obstructive Pulmonary Disease
Hersh, C. P., DeMeo, D. L., Lazarus, R., Celedón, J. C., Raby, B. A., Benditt, J. O., Criner, G., Make, B., Martinez, F. J., Scanlon, P. D., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1452oc · Cited by 129
“0001) and between modified BODE (Body mass index, airflow Obstruction, Dyspnea, Exercise tolerance) score (17) and each of its components (FEV1: r 0.”
BackgroundPulmonary function testing in COPD: looking beyond the curtain of FEV1
Kakavas, S., Kotsiou, O. S., Perlikos, F., Mermiri, M., Mavrovounis, G., Gourgoulianis, K. I., & Pantazopoulos, I. N. (2021) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-021-00236-w · Cited by 150
Tabak, Y. P., Sun, X., Johannes, R. S., Gupta, V., & Shorr, A. F. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.270 · Cited by 123
“The BODE score (body mass index, the degree of airflow obstruction and dyspnea, and exercise capacity) predicts mortality over months and requires assessment of dyspnea, exercise capacity, and other factors.(27) It has never been validated for use in AECOPD.”
BackgroundUbhi, B. K., Cheng, K. K., Dong, J., Janowitz, T., Jodrell, D. I., Tal‐Singer, R., MacNee, W., Lomas, D. A., Riley, J. H., Griffin, J. L., et al. (2012) · Molecular BioSystems · doi:10.1039/c2mb25194a · Cited by 132
Increasing awareness of sex differences in airway diseases
Raghavan, D., & Jain, R. (2015) · Respirology · doi:10.1111/resp.12702 · Cited by 138
Kaminsky, D. A., Guntupalli, K. K., Lippmann, J. E., Burns, S. M., Brock, M. A., Skelly, J. M., DeSarno, M., Pecott-Grimm, H., Mohsin, A., LaRock-McMahon, C., et al. (2017) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2017.0102 · Cited by 143
“], inspiratory time to total breathing cycle time [Ti/Ttot], 6-min walk distance [6MWD],(29) and bodymass index, airflow obstruction, dyspnea, exercise capacity [BODE] index).(30) In addition, we measured lung volumes(31) (total lung capacity [TLC], functional residual capacity [FRC], residual volume [RV]) and specifi…”
Thabut, G., Ravaud, P., Christie, J. D., Castier, Y., Fournier, M., Mal, H., Lesèche, G., & Porcher, R. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1283oc · Cited by 122
“Although COPD is debilitating, mortality from this disorder may not be as high as that from other forms of end-stage lung disease (8).”
BackgroundMurphy, P. B., Kumar, A., Reilly, C., Jolley, C., Walterspacher, S., Fedele, F., Hopkinson, N. S., Man, W. D.-C., Polkey, M. I., Moxham, J., et al. (2011) · Thorax · doi:10.1136/thx.2010.151332 · Cited by 122
Lou, P., Zhu, Y., Chen, P., Zhang, P., Yu, J., Zhang, N., Chen, N., Zhang, L., Wu, H., & Zhao, J. (2012) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-12-53 · Cited by 119
“The test was repeated twice with an interval of at least 30 minutes [20].”
MethodPuhan, M. A., Hansel, N. N., Sobradillo, P., Enright, P., Lange, P., Hickson, D. A., Menezes, A. M. B., ter Riet, G., Held, U., Domingo‐Salvany, A., et al. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-002152 · Cited by 138
“413 (99) 4538 (88) 178 (8) 61 (18) 63 (36) 51 (16)”
The COPD control panel: towards personalised medicine in COPD
Agustí, A. G. N., & MacNee, W. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202772 · Cited by 131
Chen, Z., Fan, V. S., Belza, B. L., Pike, K. C., & Nguyen, H. Q. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201701-026oc · Cited by 123
“Disease severity measures included the BODE Index (18) and oxygen use.”
InfluentialExercise assessments and trainings of pulmonary rehabilitation in COPD: a literature review
Zeng, Y., Jiang, F., Chen, Y., Chen, P., & Cai, S. (2018) · International Journal of COPD · doi:10.2147/copd.s167098 · Cited by 142
“Patients with a BODE of 7–10 were shown to survive ~3 years.(77,78) BODE is also used to calculate the health-related quality of life in COPD patients.”
MethodTask Force of GesEPOC Grupo de Trabajo de GesEPOC (2012) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(12)70035-2 · Cited by 209
Galizia, G., Cacciatore, F., Testa, G., Della‐Morte, D., Mazzella, F., Langellotto, A., Raucci, C., Gargiulo, G., Ferrara, N., Rengo, F., et al. (2011) · Aging Clinical and Experimental Research · doi:10.1007/bf03351076 · Cited by 122
Currow, D. C., Louw, S., McCloud, P., Fazekas, B. S., Plummer, J., McDonald, C. F., Agar, M. R., Clark, K., McCaffery, N., & Ekström, M. P. (2019) · Thorax · doi:10.1136/thoraxjnl-2019-213681 · Cited by 120
Chronic obstructive pulmonary disease severity and cardiovascular outcomes
Curkendall, S. M., Lanes, S., de Luise, C., Stang, M. R., Jones, J. K., She, D., & Goehring, E. L. (2006) · European Journal of Epidemiology · doi:10.1007/s10654-006-9066-1 · Cited by 135
Longitudinal Change in the BODE Index Predicts Mortality in Severe Emphysema
Martinez, F. J., Han, M. K., Andrei, A.-C., Wise, R., Murray, S., Curtis, J. L., Sternberg, A., Criner, G., Gay, S. E., Reilly, J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1383oc · Cited by 122
“As such, we report the following: (1) the mBODE is responsive to longitudinal changes with greater improvement in surgically compared with medically treated patients; (2) a decrease in mBODE of more than 1 point was predictive of lesser mortality in the entire cohort and, particularly, the surgically treated cohort; (…”
BackgroundMethodResultInfluentialSelf-citationFan, V. S., Giardino, N. D., Blough, D. K., Kaplan, R. M., Ramsey, S. D., & the NETT Research Group (2008) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550801941190 · Cited by 121
Boes, J. L., Hoff, B. A., Bule, M., Johnson, T. D., Rehemtulla, A., Chamberlain, R., Hoffman, E. A., Kazerooni, E. A., Martínez, F. J., Han, M. K., et al. (2014) · Academic Radiology · doi:10.1016/j.acra.2014.08.015 · Cited by 121
“Improvements have been made through the inclusion of FEV1 in multidimensional assessments (eg, body mass index, obstruction, dyspnea, exercise [BODE]) (6,7), which have improved prognostication over FEV1 alone.”
BackgroundRelationship of Upper-Limb and Thoracic Muscle Strength to 6-min Walk Distance in COPD Patients
Dourado, V. Z., Antunes, L. C. D. O., Tanni, S. É., de Paiva, S. A. R., Padovani, C. R., & Godoy, I. (2006) · CHEST Journal · doi:10.1378/chest.129.3.551 · Cited by 137
The value of blood cytokines and chemokines in assessing COPD
Bradford, E., Jacobson, S. R., Varasteh, J., Comellas, A. P., Woodruff, P. G., O’Neal, W. K., DeMeo, D. L., Li, X., Kim, V., Cho, M., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0662-2 · Cited by 126
“Statistical models and covariates were selected based on previous literature [9, 10, 14, 16, 25, 35, 36] as indicated in Additional file 1: Table S2.”
British Thoracic Society Clinical Statement on pulmonary rehabilitation
Man, W. D., Chaplin, E., Daynes, E., Drummond, A., Evans, R. A., Greening, N. J., Nolan, C. M., Pavitt, M. J., Roberts, N., Vogiatzis, I., et al. (2023) · Thorax · doi:10.1136/thorax-2023-220439 · Cited by 131
Celli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agusti, A. A., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · European Respiratory Review · doi:10.1183/16000617.00000315 · Cited by 130
Self-citationGallego, M., Pomares, X., Espasa, M., Castañer, E., Solé, M., Suarez, D. L., Monsó, E., & Montón, C. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-103 · Cited by 117
“At baseline, smoking history, severity of the disease, BODE index [17], comorbidities (Charlson index) [18], use of long-term home oxygen therapy, short-term treatments with antibiotics and corticosteroids and hospitalizations due to respiratory causes in the previous year were recorded.”
MethodPrimary Ciliary Dyskinesia: A Clinical Review
Despotes, K. A., Zariwala, M. A., Davis, S. D., & Ferkol, T. W. (2024) · Cells · doi:10.3390/cells13110974 · Cited by 123
“Nutritional status has been linked with lung function in several chronic respiratory conditions, including CF, chronic obstructive pulmonary disease (COPD), and non-CF bronchiectasis [32–34].”
BackgroundFederal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease
Чучалин, А. Г., Avdeev, S. N., Айсанов, З. Р., Belevskiy, А. S., Викторович, Л. И., Si, O., & Shmelev, E. I. (2022) · PULMONOLOGIYA · doi:10.18093/0869-0189-2022-32-3-356-392 · Cited by 126
Gloeckl, R., Heinzelmann, I., Baeuerle, S., Damm, E., Schwedhelm, A.-L., Diril, M., Buhrow, D., Jerrentrup, A., & Kenn, K. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.10.021 · Cited by 124
“Canuto FF, Rocco CC, de Andrade DV, Sampaio LM, Oliveira CS, Correa FI, et al. Neurophysiological comparison between the sit-to-stand test with the 6-minute walk test in individuals with COPD.”
InfluentialMid-Arm Muscle Area Is a Better Predictor of Mortality Than Body Mass Index in COPD
Soler‐Cataluña, J. J., Sánchez, L., Martínez‐García, M. Á., Sánchez, P. R., Salcedo, E., & Navarro, M. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2108 · Cited by 131
Sex Differences in Survival of Oxygen-dependent Patients with Chronic Obstructive Pulmonary Disease
Machado, M.-C. L., Krishnan, J. A., Buist, S. A., Bilderback, A. L., Fazolo, G. P., Santarosa, M. G., Queiroga, F., & Vollmer, W. M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200507-1057oc · Cited by 127
“Celli and coworkers ( 35 ) studied a multidimensional grading system, BODE (B body mass index, O airway obstruction, D dyspnea, E exercise capacity) that can predict risk of death in patients with COPD.”
BackgroundThe Association Between Metabolic Syndrome and Restrictive Ventilatory Dysfunction in Older Persons
Fimognari, F. L., Pasqualetti, P., Moro, L., Franco, A., Piccirillo, G., Pastorelli, R., Rossini, P. M., & Incalzi, R. A. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.7.760 · Cited by 127
The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD
Sundh, J., Janson, C., Lisspers, K., Ställberg, B., & Montgomery, S. (2012) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2012.00054 · Cited by 114
“The BODE index combines BMI, obstruction (FEV1%pred), dyspnoea (MRC scale), and exercise capacity measured by the 6minute walking distance (6MWD), and has also been demonstrated to predict mortality.(11,12,31,32) Exercise capacity cannot be examined easily, which makes it unsuitable for most clinical settings.”
BackgroundMethodHerigstad, M., Hayen, A., Wiech, K., & Pattinson, K. T. S. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2010.12.022 · Cited by 131
Prediction models for exacerbations in patients with COPD
Guerra, B., Gaveikaite, V., Bianchi, C., & Puhan, M. A. (2017) · European Respiratory Review · doi:10.1183/16000617.0061-2016 · Cited by 125
Foglio, K., Bianchi, L. N. C., Bruletti, G., Porta, R., Vitacca, M., Balbi, B., & Ambrosino, N. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.04.007 · Cited by 123
Dvir, D., Waksman, R., Barbash, I. M., Kodali, S. K., Svensson, L. G., Tuzcu, E. M., Xu, K., Minha, S., Alu, M. C., Szeto, W. Y., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.024 · Cited by 112
New drugs for exacerbations of chronic obstructive pulmonary disease
Hansel, T. T., & Barnes, P. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61342-8 · Cited by 117
The respiratory threat posed by multidrug resistant Gram‐negative bacteria
Rodrigo‐Troyano, A., & Sibila, O. (2017) · Respirology · doi:10.1111/resp.13115 · Cited by 110
Kawagoshi, A., Kiyokawa, N., Sugawara, K., Takahashi, H., Sakata, S., Satake, M., & Shioya, T. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.01.008 · Cited by 123
“The BODE index (bodymass index, airflow obstruction, dyspnea, and exercise capacity index) [27] was assessed as a prognosis factor for COPD patients.”
MethodDignity and Distress towards the End of Life across Four Non-Cancer Populations
Chochinov, H. M., Johnston, W. S. W., McClement, S., Hack, T. F., Dufault, B., Enns, M. W., Thompson, G. N., Harlos, M., Damant, R. W., Ramsey, C. D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147607 · Cited by 119
“This is consistent with prior studies and prognostic models [44], underscoring the observation that patients with COPD have a less predictable terminal course, posing a barrier to the earlier initiation of palliative care [45].”
Gückenberger, M., Kestin, L. L., Hope, A. J., Belderbos, J. S. A., Werner‐Wasik, M., Yan, D., Sonke, J., Bissonnette, J. P., Wilbert, J., Xiao, Y., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824165d7 · Cited by 111
Gea, J., Sancho‐Muñoz, A., & Chalela, R. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.02.66 · Cited by 125
“In fact, only the BODE index and its derivates include body mass index (BMI) among variables used to determine the severity and prognosis of the disease (110).”
MethodRodriguez‐Roisin, R., Rabe, K. F., Vestbo, J., Vogelmeier, C. F., & Agustí, A. G. N. (2017) · European Respiratory Journal · doi:10.1183/13993003.00671-2017 · Cited by 113
Chronic Obstructive Pulmonary Disease in Patients Undergoing Transcatheter Aortic Valve Implantation
Mok, M., Nombela-Franco, L., Dumont, E., Urena, M., DeLarochellière, R., Doyle, D., Villeneuve, J., Côté, M., Ribeiro, H. B., Allende, R., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.06.008 · Cited by 110
“In pulmonary medicine, studies of patients with COPD have identified a number of prognostic markers for all-cause mortality (10,11), death from respiratory causes, as well as hospitalization for acute exacerbations (12).”
BackgroundAndrianopoulos, V., Wouters, E. F. �., Pinto-Plata, V., Vanfleteren, L. E. G. W., Bakke, P. S., Franssen, F. M. E., Agustí, A. G. N., MacNee, W., Rennard, S. I., Tal‐Singer, R., et al. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.06.013 · Cited by 123
“The BODE index was calculated using the algorithm developed by Celli and colleagues [17].”
Self-citationComorbidities and Burden of COPD: A Population Based Case-Control Study
Baty, F., Putora, P. M., Isenring, B. D., Blum, T. G., & Brutsche, M. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063285 · Cited by 110
It’s more than low BMI: prevalence of cachexia and associated mortality in COPD
McDonald, M., Wouters, E. F. �., Rutten, E. P. A., Casaburi, R. H., Rennard, S. I., Lomas, D. A., Bamman, M. M., Celli, B. R., Agustí, A. G. N., Tal‐Singer, R., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1073-3 · Cited by 117
Self-citationExercise Capacity Deterioration in Patients With COPD
Oga, T., Nishimura, K., Tsukino, M., Satô, S., Hajiro, T., & Mishima, M. (2005) · CHEST Journal · doi:10.1378/chest.128.1.62 · Cited by 123
Anti-Tissue Antibodies Are Related to Lung Function in Chronic Obstructive Pulmonary Disease
Núñez, B., Sauleda, J., Antó, J. M., Juliá, M. R., Orozco‐Levi, M., Monsó, E., Noguera, A., Gómez, F. P., García‐Aymerich, J., & Agustí, A. G. N. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0029oc · Cited by 110
Current Controversies and Future Perspectives in Chronic Obstructive Pulmonary Disease
Agustí, A., & Vestbo, J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0405pp · Cited by 111
Perez, T., Burgel, P., Paillasseur, J.-L., Caillaud, D. M., Deslée, G., Chanez, P., & Roche, N. (2015) · International Journal of COPD · doi:10.2147/copd.s82408 · Cited by 108
“9 Moreover, evaluation of the level of dyspnea by the mMRC is now used to categorize COPD symptomatic burden in the new Global initiative for chronic Obstructive Lung Disease (GOLD) recommendations and provides useful information about COPD-induced disability.”
Marquis, N., Larivée, P., Saey, D., Dubois, M., & Tousignant, M. (2015) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2014.0198 · Cited by 115
“43,45 The CET is a constant-load test performed on a stationary bicycle that is increasingly used to estimate the efficacy of PR for patients with COPD by measuring endurance capacity at a preset intensity of work.”
Soyza, A. D., McDonnell, M. J., Goeminne, P., Aliberti, S., Lonni, S., Davison, J., Dupont, L., Fardon, T. C., Rutherford, R. M., Hill, A. T., et al. (2017) · CHEST Journal · doi:10.1016/j.chest.2016.12.024 · Cited by 109
“The mortality rates in the BCOS population were high and in the order of those reported in patients with Global Initiative for Chronic Obstructive Lung Disease stage II/ III COPD (or those within body mass index, airflow obstruction, dyspnea, exercise capacity [BODE] index quartile 3) in the BODE index cohort and in o…”
ResultAnemia in COPD: A Systematic Review of the Prevalence, Quality of Life, and Mortality
Yohannes, A. M., & Ershler, W. B. (2011) · Respiratory Care · doi:10.4187/respcare.01002 · Cited by 116
Bai, P., Sun, Y., Jin, J., Hou, J., Li, R., Zhang, Q., & Wang, Y. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-157 · Cited by 109
“[23], based on the following four variables: (1) FEV1 percentage of predicted (≥ 65%, score 0; 50% to 64%, score 1; 36% to 49%, score 2; and ≤ 35%, score 3); (2) Six-minute walking distance (6MWD) (≥ 350 m, score 0; 250 to 349 m, score 1; 150 to 249 m, score 2; ≤149 m, score 3); (3) MMRC dyspnea score (0 to 1, score 0…”
Patient-Reported Dyspnea in COPD Reliability and Association With Stage of Disease
Mahler, D. A., Ward, J., Waterman, L. A., McCusker, C., ZuWallack, R., & Baird, J. C. (2009) · CHEST Journal · doi:10.1378/chest.09-0934 · Cited by 108
A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD
Hutchinson, A. F., Ghimire, A., Thompson, M. A., Black, J., Brand, C. A., Lowe, A. J., Smallwood, D. M., Vlahos, R., Bozinovski, S., Brown, G. V., et al. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.015 · Cited by 124
“Potential predictors tested using univariate analysis were; age, sex, smoking status, disease severity, COPD sub-type and functional status (measured by BODE Index).(21) Cluster analysis was used to adjust for repeated AECOPD from the same individual—this technique adjusts the standard error around the estimate of ass…”
MethodFu, J., Gibson, P. G., Simpson, J. L., & McDonald, V. M. (2013) · Respiration · doi:10.1159/000352053 · Cited by 111
Imbalances Between Interleukin-1 and Tumor Necrosis Factor Agonists and Antagonists in Stable COPD
Sapey, E., Ahmad, A., Bayley, D., Newbold, P., Snell, N. J. C., Rugman, P., & Stockley, R. A. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9286-8 · Cited by 105
“Sputum production may be related to an accelerated decline in lung function in COPD [53, 54], and mucus hyper-secretion is associated with death from respiratory infections [55].”
BackgroundSignificance of changes in endurance shuttle walking performance
Pepin, V., Laviolette, L., Brouillard, C., Sewell, L., Singh, S. J., Revill, S. M., Lacasse, Y., & Maltais, F. (2011) · Thorax · doi:10.1136/thx.2010.146159 · Cited by 109
“Despite the fact that they both involve walking, the ESWT and the 6-MWT have very different designs and properties. As such, the choice of the test that should be used in a given clinical or research situation should be based on the specific question being asked. The discriminative properties of the 6-MWT have been es…”
BackgroundMulticomponent indices to predict survival in COPD: the COCOMICS study
Marín, J. M., Alfageme, I., Almagro, P., Casanova, C., Esteban, C., Soler‐Cataluña, J. J., de-Torres, J. P., Martínez‐Camblor, P., Miravitlles, M., Celli, B. R., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00121012 · Cited by 120
Self-citationTeste de caminhada de seis minutos: uma ferramenta valiosa na avaliação do comprometimento pulmonar
Morales-Blanhir, J. E., Palafox, D., Romero, M. D. J. R. R., Castro, M. M. G., Villegas, A. L., & Zamboni, M. M. (2011) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132011000100016 · Cited by 151
“(41-50) Como preditor de mortalidade em pacientes que são candidatos a transplante de pulmão, o TC6 demonstrou elevada sensibilidade; uma DTC6 de menos de 300 m foi associada a mortalidade muito mais precoce em paciente na lista de espera para transplante.(26) Recentemente, que um dos fatores que determinava a DTC6 er…”
BackgroundOostenbrink, J. B., Mölken, M. R., Monz, B. U., & FitzGerald, J. M. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.03086.x · Cited by 104
Inspiratory fraction and exercise impairment in COPD patients GOLD stages II–III
Albuquerque, A. L. P., Nery, L. E., Villaça, D. S., Machado, T. Y. S., Oliveira, C. C., Paes, Â. T., & Neder, J. A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00040506 · Cited by 74
Clinical characteristics of the asthma–COPD overlap syndrome – a systematic review
Ulrik, C. S., Nielsen, M. R. I., & Bårnes, C. B. (2015) · International Journal of COPD · doi:10.2147/copd.s85363 · Cited by 105
“The BODE index (ie, Body mass index, airflow Obstruction, Dyspnea and Exercise capacity) was applied for evaluation of the enrolled patients.(31) The BODE score was significantly higher in the ACOS group (3.”
Methodwith chronic obstructive pulmonary disease Severe acute exacerbations and mortality in patients
Ochando, R., Soler‐Cataluña, J. J., Martínez‐García, M. Á., Sánchez, P. R., Salcedo, E., & Navarro, M. (2006) · Cited by 103
Global, Race-Neutral Reference Equations and Pulmonary Function Test Interpretation
Moffett, A. T., Bowerman, C., Stanojevic, S., Eneanya, N. D., Halpern, S. D., & Weissman, G. E. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.16174 · Cited by 112
Vlahos, R., Bozinovski, S., Hamilton, J. A., & Anderson, G. P. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.03.007 · Cited by 112
“Alternative scales, such as the BODE index, have been proposed and may offer a more comprehensive measure of disability as they also include systemic wasting indices (Celli et al., 2004).”
BackgroundQuality of Life in Lung Transplantation
Singer, L., & Singer, J. (2013) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0033-1348470 · Cited by 95
Martínez, F. J., Donohue, J. F., & Rennard, S. I. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61047-7 · Cited by 103
Beclomethasone/formoterol in the management of COPD: A randomised controlled trial
Calverley, P. M. A., Kuna, P., Monsó, E., Costantini, M., Petruzzelli, S., Sergio, F., Varoli, G., Papi, A. A., & Brusasco, V. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.09.008 · Cited by 101
Six Minute Walk Test to assess functional capacity in chronic liver disease patients
Alameri, H. F., Sanai, F. M., Dukhayil, M. A., Azzam, N. A., Al-Swat, K. A., Hersi, A. S., & Abdo, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i29.3996 · Cited by 118
Annegarn, J., Spruit, M. A., Savelberg, H. H. C. M., Willems, P. J. B., van de Bool, C., Schols, A. M. W. J., Wouters, E. F. �., & Meijer, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037329 · Cited by 100
“It is therefore more likely that in COPD patients walking stability is influenced by dyspnea [30], altered breathing dynamics [31], reduced arm swing, [32], lower muscle strength and/or coordination [5,6], disturbed balance [7,33], or a combination thereof.”
BackgroundYamauchi, Y., Hasegawa, W., Yasunaga, H., Sunohara, M., Jo, T., Matsui, H., Fushimi, K., Takami, K., & Nagase, T. (2014) · International Journal of COPD · doi:10.2147/copd.s75175 · Cited by 108
The BODE Index After Lung Volume Reduction Surgery Correlates With Survival
Imfeld, S., Bloch, K. E., Weder, W., & Russi, E. W. (2006) · CHEST Journal · doi:10.1378/chest.129.4.873 · Cited by 109
Matković, Z., Huerta, A. H., Soler, N., Domingo, R., Gabarrús, A., Torres, A., & Miravitlles, M. (2012) · Respiration · doi:10.1159/000335467 · Cited by 100
Leavitt, B. J., Ross, C. S., Spence, B. C., Surgenor, S. D., Olmstead, E. M., Clough, R. A., Charlesworth, D. C., Kramer, R. S., & O’Connor, G. T. (2006) · Circulation · doi:10.1161/circulationaha.105.000943 · Cited by 100
Mentz, R. J., Schulte, P. J., Fleg, J. L., Fiuzat, M., Kraus, W. E., Piña, I. L., Keteyian, S. J., Kitzman, D. W., Whellan, D. J., Ellis, S. J., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.10.029 · Cited by 105
Skeletal muscle dysfunction in COPD: clinical and laboratory observations
Man, W. D., Kemp, P. R., Moxham, J., & Polkey, M. I. (2009) · Clinical Science · doi:10.1042/cs20080659 · Cited by 118
Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients
Takigawa, N., Tada, A., Soda, R., Date, H., Yamashita, M., Endo, S., Takahashi, S., Kawata, N., Shibayama, T., Hamada, N., et al. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.06.017 · Cited by 113
Recommendations for epidemiological studies on COPD
Quanjer, P. H., Stanojevic, S., Swanney, M. P., & Miller, M. R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00224411 · Cited by 100
Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE
de-Torres, J. P., Casanova, C., Marín, J. M., Pinto-Plata, V., Divo, M. J., Zulueta, J. J., Bertó, J., Zagaceta, J., Sánchez-Salcedo, P., Cabrera, C., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205770 · Cited by 99
Self-citationPison, C. M., Cano, N. J., Cherion, C., Caron, F., Court-Fortune, I., Antonini, M.-T., Gonzalez-Bermejo, J., Meziane, L., Molano, L. C., Janssens, J.-P., et al. (2011) · Thorax · doi:10.1136/thx.2010.154922 · Cited by 93
Pompe, E., Galbán, C. J., Ross, B. D., Koenderman, L., ten Hacken, N. H. T., Postma, D. S., van den Berge, M., de Jong, P. A., Lammers, J. J., & Hoesein, F. A. A. M. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.11.021 · Cited by 100
“The BODE-index was calculated based on FEV1, the 6MWD, BMI, and the MRC-dyspnea score [17].”
MethodLong-term survival following initiation of home non-invasive ventilation: a European study
Patout, M., Lhuillier, E., Kaltsakas, G., Benattia, A., Dupuis, J., Arbane, G., Declercq, P.-L., Ramsay, M., Marino, P. S., Molano, L.-C., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214204 · Cited by 107
“…had a similar survival to patients in the fourth quartile of the BODE (body mass index, airflow obstruction, dyspnoea and exercise capacity) index, 25 and therefore initiation of home NIV should trigger evaluation for lung transplantation or palliative care referral if lung transplantation is not…”
Kelly, J. L., Bamsey, O., Smith, C., Lord, V. M., Shrikrishna, D., Jones, P. W., Polkey, M. I., & Hopkinson, N. S. (2012) · Respiration · doi:10.1159/000336549 · Cited by 99
Metadata
- Authors
- Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J.
- Affiliations
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Hospital Clínico Universitario de Caracas (VE)
- Boston University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-03-04
- Volume
- 350
- Issue
- 10
- Pages
- 1005-1012
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139347600
- Semantic Scholar
- 12606ed46f2e1cd6f56b679b445a8fda29690f65
- Cited by
- 4,015
- References
- 36
- Citations by year
- 2026: 88 · 2025: 115 · 2024: 153 · 2023: 132 · 2022: 124 · 2021: 176 · 2020: 199 · 2019: 158 · 2018: 192 · 2017: 184 · 2016: 206 · 2015: 185 · 2014: 241 · 2013: 230 · 2012: 242
- FWCI
- 135.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- chronic obstructive pulmonary disease, BODE index, body mass index, airflow obstruction, dyspnea, exercise capacity, 6-minute walk test, mortality prediction, FEV1, disease severity classification, respiratory mortality
- MeSH terms
- Aged, Airway Obstruction, Dyspnea, Forced Expiratory Volume, Humans, Middle Aged, Prospective Studies, Risk, Risk Factors, Severity of Illness Index, Body Mass Index, Exercise Tolerance, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.